Microcephalic Osteodysplastic Primordial Dwarfism Type II With Associated Glucose-6-Phosphate Dehydrogenase

Fadi Busaleh1, Haider Alnofaily1, Hussain A Al Ghadeer1

  • 1Pediatrics, Maternity and Children Hospital, Al-Ahsa, SAU.

Cureus
|December 29, 2021
PubMed

Insights

Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is a rare growth disorder. This case report details an infant with MOPDII and glucose-6-phosphate dehydrogenase deficiency anemia in Saudi Arabia.

Area of Science:

  • Genetics and rare diseases
  • Pediatric endocrinology
  • Hematology

Background:

  • Microcephalic primordial dwarfism encompasses rare genetic disorders characterized by severe growth restriction.
  • Microcephalic osteodysplastic primordial dwarfism type II (MOPDII) is the most common subtype, yet remains exceptionally rare globally.
  • Existing literature on MOPDII is limited, underscoring the importance of case reports.

Observation:

  • This report describes a unique case of MOPDII in an infant residing in Saudi Arabia.
  • The infant presented with characteristic features of MOPDII, including significant growth restriction.
  • Notably, the infant also exhibited glucose-6-phosphate dehydrogenase deficiency, leading to hemolytic anemia.

Findings:

  • The co-occurrence of MOPDII and glucose-6-phosphate dehydrogenase deficiency anemia in this infant is a significant clinical observation.
  • This presentation expands the known clinical spectrum of MOPDII.
  • The findings highlight the importance of comprehensive genetic and metabolic evaluations in patients with primordial dwarfism.

Implications:

  • This case contributes valuable data to the limited global understanding of MOPDII.
  • It emphasizes the need for increased awareness and reporting of rare genetic conditions in diverse geographical regions.
  • Further research into the potential genetic or clinical links between MOPDII and G6PD deficiency is warranted.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
296
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
25.7K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Pedigree Analysis01:35

Pedigree Analysis

Overview
85.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.7K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
2.2K